These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20621521)

  • 21. Risk Factors for Cerebral Infarction in Duchenne Muscular Dystrophy: Review With our 2 Cases.
    Nozaki F; Kusunoki T; Kumada T; Shibata M; Fujii T
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2453-2458. PubMed ID: 31311695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystrophin-Deficient Cardiomyopathy.
    Kamdar F; Garry DJ
    J Am Coll Cardiol; 2016 May; 67(21):2533-46. PubMed ID: 27230049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
    El-Aloul B; Altamirano-Diaz L; Zapata-Aldana E; Rodrigues R; Malvankar-Mehta MS; Nguyen CT; Campbell C
    Neuromuscul Disord; 2017 Jan; 27(1):4-14. PubMed ID: 27815032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
    Townsend D; Yasuda S; Metzger J
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
    Hor KN; Mazur W; Taylor MD; Al-Khalidi HR; Cripe LH; Jefferies JL; Raman SV; Chung ES; Kinnett KJ; Williams K; Gottliebson WM; Benson DW
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):60. PubMed ID: 22011358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy.
    American Academy of Pediatrics Section on Cardiology and Cardiac Surgery
    Pediatrics; 2005 Dec; 116(6):1569-73. PubMed ID: 16322188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilateral Cerebral Infarctions and Intracardiac Thrombus in a Young Duchenne Muscular Dystrophy Patient.
    Qiao Y; Inoue M; Kikuno M; Peng D; Liu Z; Toyoda K
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e150-e152. PubMed ID: 29571762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac management in neuromuscular diseases.
    Allen HD; Thrush PT; Hoffman TM; Flanigan KM; Mendell JR
    Phys Med Rehabil Clin N Am; 2012 Nov; 23(4):855-68. PubMed ID: 23137741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pericardial effusion with cardiac tamponade as a cardiac manifestation of Duchenne muscular dystrophy.
    Lin JJ; Hwang MS; Hsia SH; Chung HT; Chang YS; Lin KL
    Muscle Nerve; 2009 Sep; 40(3):476-80. PubMed ID: 19623636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs.
    Colan SD
    Circulation; 2005 Nov; 112(18):2756-8. PubMed ID: 16267247
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy.
    Cheng VE; Prior DL
    Heart Lung Circ; 2013 Aug; 22(8):677-81. PubMed ID: 23279916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
    Duboc D; Meune C; Lerebours G; Devaux JY; Vaksmann G; Bécane HM
    J Am Coll Cardiol; 2005 Mar; 45(6):855-7. PubMed ID: 15766818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
    Doing AH; Renlund DG; Smith RA
    J Heart Lung Transplant; 2002 Apr; 21(4):496-8. PubMed ID: 11927228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete atrioventricular block in Duchenne muscular dystrophy.
    Fayssoil A; Orlikowski D; Nardi O; Annane D
    Europace; 2008 Nov; 10(11):1351-2. PubMed ID: 18815187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
    Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy.
    Chabrier S; Desguerre I; Porte M; Payet C; Rivier F;
    Dev Med Child Neurol; 2010 Nov; 52(11):1067-8. PubMed ID: 20636389
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic review of pharmacologic therapies for the cardiomyopathy of Duchenne muscular dystrophy.
    Kipke J; Birnkrant DJ; Jin JB; Aneja A; Bahler RC
    Pediatr Pulmonol; 2021 Apr; 56(4):782-795. PubMed ID: 33621446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.